SEC
KITE

Seven Eight Capital’s Kite Pharma, Inc. KITE Stock Holding History

Seven Eight Capital’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,163
Closed -$928K – 648
2017
Q3 		$928K Sell
5,163
-3,900
-43% -$543K 0.11% 263
2017
Q2 		$940K Buy
9,063
+8,276
+1,052% +$675K 0.14% 220
2017
Q1 		$62K Sell
787
-3,600
-82% -$223K 0.01% 423
2016
Q4 		$197K Sell
4,387
-22,631
-84% -$1.11M 0.04% 405
2016
Q3 		$1.51M Buy
+27,018
New +$1.51M 0.44% 74
2016
Q2 		– Sell
-2,117
Closed -$97K – 734
2016
Q1 		$97K Buy
+2,117
New +$103K 0.04% 393
2015
Q4 		– Sell
-38
Closed -$2K – 758
2015
Q3 		$2K Sell
38
-2,034
-98% -$128K ﹤0.01% 498
2015
Q2 		$126K Buy
2,072
+572
+38% +$32.6K 0.15% 228
2015
Q1 		$87K Buy
+1,500
New +$101K 0.15% 226

Seven Eight Capital's KITE Position: Q4 2017 in Review

Seven Eight Capital sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 5,163 shares — an estimated $928K sold.

Seven Eight Capital first reported a position in KITE in Q1 2015 and held it in 9 quarters. The position peaked at $1.51M in Q3 2016. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Seven Eight Capital reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Seven Eight Capital sold 5,163 Kite Pharma, Inc. shares in Q4 2017, an estimated $928K.
  • Seven Eight Capital first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 9 quarters.
  • Seven Eight Capital's Kite Pharma, Inc. position peaked at $1.51M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Seven Eight Capital's 13F filing for Q4 2017, filed 12 Feb 2018.